VYEPTI
Google image searchProduct monograph
Active ingredient
eptinezumab, 100 MG/ML
DIN: 02510839
Dosage form(s): SOLUTION
Route(s) of administration: INTRAVENOUS
Description: SINGLE USE VIAL
Schedule: Prescription / Schedule D
Company: LUNDBECK CANADA INC
Date: 17-AUG-2022
ATC:
- N02 — ANALGESICS (ATC, ATC/DDD, )
- N02C — ANTIMIGRAINE PREPARATIONS (ATC, ATC/DDD)
- N02CD — Calcitonin gene-related peptide (CGRP) antagonists (ATC, ATC/DDD)
- N02CD05 — EPTINEZUMAB (ATC/DDD)
External Links for Vyepti
Search on Google
Lundbeck Canada Inc
Go to Lundbeck website to see drug product details. Sometimes you can find vyepti photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.